CZ122495A3 - Process for preparing taxan derivatives - Google Patents

Process for preparing taxan derivatives

Info

Publication number
CZ122495A3
CZ122495A3 CZ951224A CZ122495A CZ122495A3 CZ 122495 A3 CZ122495 A3 CZ 122495A3 CZ 951224 A CZ951224 A CZ 951224A CZ 122495 A CZ122495 A CZ 122495A CZ 122495 A3 CZ122495 A3 CZ 122495A3
Authority
CZ
Czechia
Prior art keywords
preparing
taxan derivatives
taxan
derivatives
preparing taxan
Prior art date
Application number
CZ951224A
Other languages
Czech (cs)
English (en)
Inventor
Jean-Dominique Bourzat
Alain Commercon
Dominique Deprez
Jean-Pierre Pulicani
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of CZ122495A3 publication Critical patent/CZ122495A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B3/00—Electrolytic production of organic compounds
    • C25B3/20—Processes
    • C25B3/25—Reduction
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B11/00—Electrodes; Manufacture thereof not otherwise provided for
    • C25B11/04—Electrodes; Manufacture thereof not otherwise provided for characterised by the material
    • C25B11/042—Electrodes formed of a single material
    • C25B11/046—Alloys
    • C—CHEMISTRY; METALLURGY
    • C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
    • C25B—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES FOR THE PRODUCTION OF COMPOUNDS OR NON-METALS; APPARATUS THEREFOR
    • C25B9/00—Cells or assemblies of cells; Constructional parts of cells; Assemblies of constructional parts, e.g. electrode-diaphragm assemblies; Process-related cell features
    • C25B9/17—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof
    • C25B9/19—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms
    • C25B9/23—Cells comprising dimensionally-stable non-movable electrodes; Assemblies of constructional parts thereof with diaphragms comprising ion-exchange membranes in or on which electrode material is embedded

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Metallurgy (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CZ951224A 1992-11-12 1993-11-10 Process for preparing taxan derivatives CZ122495A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9213586A FR2697841B1 (fr) 1992-11-12 1992-11-12 Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
CZ122495A3 true CZ122495A3 (en) 1995-12-13

Family

ID=9435452

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ951224A CZ122495A3 (en) 1992-11-12 1993-11-10 Process for preparing taxan derivatives

Country Status (15)

Country Link
EP (1) EP0667922A1 (es)
JP (1) JPH08503261A (es)
KR (1) KR950704540A (es)
AU (1) AU5425794A (es)
CA (1) CA2149240A1 (es)
CZ (1) CZ122495A3 (es)
FI (1) FI952294A (es)
FR (1) FR2697841B1 (es)
MX (1) MX9306883A (es)
NO (1) NO951772L (es)
PL (1) PL308957A1 (es)
RU (1) RU95112464A (es)
SK (1) SK60895A3 (es)
WO (1) WO1994011547A1 (es)
ZA (1) ZA938366B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
FR2710642B1 (fr) * 1993-09-29 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2711369B1 (fr) * 1993-10-20 1995-11-17 Rhone Poulenc Rorer Sa Nouveaux taxoïdes, leur préparation et les compositions qui les contiennent.
US5919815A (en) * 1996-05-22 1999-07-06 Neuromedica, Inc. Taxane compounds and compositions
EP0914116B1 (en) * 1996-05-22 2000-10-11 Protarga Inc. Compositions comprising conjugates of cis-docosahexaenoic acid and taxotere
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
US8309603B2 (en) 2004-06-07 2012-11-13 University Of Tennessee Research Foundation SARMs and method of use thereof
MXPA06008293A (es) * 2004-01-22 2007-06-11 Univ Miami Formulaciones topicas de coenzima q10 y metodos de uso.
US9889110B2 (en) 2004-06-07 2018-02-13 University Of Tennessee Research Foundation Selective androgen receptor modulator for treating hormone-related conditions
US9884038B2 (en) 2004-06-07 2018-02-06 University Of Tennessee Research Foundation Selective androgen receptor modulator and methods of use thereof
US9730908B2 (en) 2006-08-24 2017-08-15 University Of Tennessee Research Foundation SARMs and method of use thereof
US10010521B2 (en) 2006-08-24 2018-07-03 University Of Tennessee Research Foundation SARMs and method of use thereof
US9844528B2 (en) 2006-08-24 2017-12-19 University Of Tennessee Research Foundation SARMs and method of use thereof
US7968603B2 (en) 2007-09-11 2011-06-28 University Of Tennessee Research Foundation Solid forms of selective androgen receptor modulators
EA201101522A1 (ru) 2009-05-11 2012-09-28 БЕРГ БАЙОСИСТЕМЗ, ЭлЭлСи Способы лечения болезней с использованием эпиметаболического переключателя (коэнзим q10)
EP2694463B8 (en) 2011-04-04 2019-10-09 Berg LLC Treating central nervous system tumors with coenzyme q10
US9622992B2 (en) 2012-07-13 2017-04-18 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
US10258596B2 (en) 2012-07-13 2019-04-16 Gtx, Inc. Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS)
US9744149B2 (en) 2012-07-13 2017-08-29 Gtx, Inc. Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs)
WO2014168993A1 (en) 2013-04-08 2014-10-16 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
WO2015035094A1 (en) 2013-09-04 2015-03-12 Berg Llc Methods of treatment of cancer by continuous infusion of coenzyme q10

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
NO951772D0 (no) 1995-05-05
FI952294A0 (fi) 1995-05-11
KR950704540A (ko) 1995-11-20
FR2697841B1 (fr) 1995-01-13
CA2149240A1 (fr) 1994-05-26
SK60895A3 (en) 1996-03-06
MX9306883A (es) 1995-01-31
ZA938366B (en) 1994-06-13
WO1994011547A1 (fr) 1994-05-26
FR2697841A1 (fr) 1994-05-13
PL308957A1 (en) 1995-09-04
EP0667922A1 (fr) 1995-08-23
NO951772L (no) 1995-05-05
FI952294A (fi) 1995-05-11
JPH08503261A (ja) 1996-04-09
RU95112464A (ru) 1997-02-20
AU5425794A (en) 1994-06-08

Similar Documents

Publication Publication Date Title
SG55048A1 (en) Process for preparing 2-para-dioxanones
CZ122495A3 (en) Process for preparing taxan derivatives
HU910400D0 (en) Process for producing 3-aryl-carbonyl-1h-indole derivatives
HU911492D0 (en) Process for producing bis-aryl-amide and -urea derivatives
GB2257149B (en) Process for preparing polyoxyalkylene- or alkylpolyglucoside- carboxylates
HUP9900318A3 (en) Process for preparing 4-aryl-piperidine derivatives
HU9400474D0 (en) Process for producing 2-amido-4-phenyl-thiazol derivatives
CZ135795A3 (en) Process for preparing benzopyran derivatives
IL105328A0 (en) Process for preparing piperidine derivatives
HUT62903A (en) Process for producing cefalosporin derivatives
HUT64030A (en) Process for producing dialkyl-2,3-pyridinedicarboxylate derivatives
IL118992A (en) Process for preparing norbenzomorphan derivatives
GR910100427A (en) Process for preparing 8-chloroquinolone derivatives
HU912693D0 (en) Process for producing indolo-naphtyridine derivatives
HU912732D0 (en) Process for producing 1-alkyl-isoquinoline derivatives
IL111829A0 (en) Process for preparing imidazopyridine derivatives
HUT62860A (en) Process for producing 5-substituted-2-chloropyridine derivatives
HU910326D0 (en) Process for producing 2-chloro-5-methyl-pyridine derivatives
EP0503603A3 (en) Process for preparing 2-exo-methylene-penam derivatives
CZ70895A3 (en) Process for preparing substituted 5-formylimidazole compounds
EP0503294A3 (en) Process for preparing perfluorpolyetheracrylfluorides
HUT67269A (en) Process for preparing benzofuranyl-imidazole derivatives
HU912413D0 (en) Process for producing n-alkyl-sulfonyl-amino-sulfonyl-urea derivatives
HUT62298A (en) Process for producing heterocyclic amidoprostaglandin derivatives
GB9424890D0 (en) Process for preparing pyrolizine derivatives